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The role of lifestyle in development of herpes zoster remains unclear. We examined whether 
smoking status, alcohol consumption, body mass index (BMI), or physical activity were associated 
with zoster risk. We followed a population-based cohort of 101,894 respondents to the 2010 Danish 
National Health Survey (baseline May 1, 2010) until zoster diagnosis, death, emigration, or July 1, 
2014, whichever occurred first. We computed hazard ratios for zoster associated with each exposure, 
using Cox regression with age as the time-scale and adjusting for potential confounders. Compared 
with never smokers, hazards for zoster were increased in former smokers [1.17; 95% confidence 
interval (CI): 1.06, 1.30], but not in current smokers (1.00; 95% CI: 0.89, 1.13). Compared with low-
risk alcohol consumption, neither intermediate-risk (0.95; 95% CI: 0.84, 1.07) nor high-risk alcohol 
consumption (0.99; 95% CI: 0.85, 1.15) were associated with zoster. We also found no increased 
hazard associated with weekly binge drinking vs. not (0.93; 95% CI: 0.77, 1.11). Risk of zoster 
varied little by BMI (referent=normal weight) and physical activity levels (referent=light level), with 
HRs between 0.96 and 1.08. We observed no dose-response association between the exposures and 
zoster. The examined lifestyle and anthropometric factors thus were not risk factors for zoster. 
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Herpes zoster (shingles) is characterized as a unilateral vesicular exanthema with acute neuritis (1). It 
is caused by varicella-zoster virus, which is acquired during primary infection (chickenpox) where it 
establishes latency in sensory ganglia making the person at risk of developing zoster later in life if 
cell-mediated immunity fails to suppress viral activity. Although roughly one-third of the population 
contracts zoster during the life course (1), there are few well-established risk factors for reactivation 
besides female sex, increasing age, and immunosuppressive treatments and diseases, e.g. 
glucocorticoids, chemotherapy, and hematological cancer (1,2).  
Earlier studies suggested that cigarette smoking (3), excessive alcohol intake (4), overweight 
(5), and vigorous physical activity (6) are immunosuppressive. As reduced cell-mediated immunity is 
a risk factor for reactivation of varicella-zoster virus, such habits could in turn trigger zoster. 
However, results from epidemiological studies have been inconsistent. Several studies reported a 
decreased relative risk of zoster among smokers (particularly current smokers) (7-12), while others 
found no association (13-18). A single small case-control study reported an association with alcohol 
consumption (odds ratio of 3.8) (16); otherwise, no substantial associations with zoster have been 
observed for alcohol consumption (7,8,14,16,17), body mass index (BMI) (7,8,14,17,19), or physical 
activity (8). Interpretation of existing evidence is hampered by crude categorization of exposures; 
particularly there is a lack of dose-response analyses. Furthermore, studies were limited by potential 
confounding and small sample sizes.  
Zoster can lead to serious acute and chronic complications, including post-herpetic neuralgia—
a debilitating condition causing prolonged pain, decreased quality of life, and possible loss of 
functional capacity (1). Given the high lifetime prevalence and these potential individual and societal 
implications of zoster, identification of modifiable risk factors is a priority. We conducted a large 
population-based cohort study in Denmark to examine whether lifestyle and anthropometric factors, 
including smoking habits, alcohol consumption, BMI, and physical activity, were associated with 
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risk of zoster, taking important confounding factors into account and evaluating possible dose-




The study cohort comprised participants in the nationwide Danish National Health Survey, 
conducted in 2010 (20) among Danish inhabitants aged ≥16 years on January 1, 2010. Participants 
were sampled through the Civil Registration System’s database of Danish residents (21). Of 298,850 
persons invited, 60% responded to the Survey, which included questions about sociodemographic 
characteristics, health-related quality of life, health behavior, morbidity, consequences of illness, and 
social relations (20).  
We had access to selected Survey variables for the population aged ≥25 years on January 1, 
2010. Questionnaire collection was completed on May 1, 2010, which we defined as baseline. We 
excluded persons who completed the questionnaire but died or emigrated before completion of 
collection. We linked the survey data to records of hospital diagnoses and treatment in the Danish 
National Patient Registry (22) and the Danish Central Psychiatric Research Registry (23), as well as 
to prescriptions recorded in the Danish National Prescription Registry (24), demographic and vital 
status data in the Civil Registration System (21), and education level recorded in the Population 
Education Registry (25). Further information on the Survey and the registries used in the study is 




We used information from the Survey to study several aspects of lifestyle and their association with 
subsequent risk of zoster. Table 1 lists definitions and working hypotheses for the exposures of 
interest, including how they may impact the immune system and thus increase zoster risk. Detailed 
code lists for all study variables are presented in Web Table 1.  
 
Outcome 
We followed persons from baseline until zoster diagnosis, death, emigration, or July 1, 2014, 
whichever came first. We used a validated algorithm (26) to identify zoster as (1) a first-time 
inpatient, outpatient clinic (ambulatory), or emergency room primary or secondary hospital registry 
diagnosis of this condition recorded in the Danish National Patient Registry or (2) a first-time 
prescription for 35 pills of acyclovir at a 800-mg dose or for valacyclovir or famciclovir at a 500-mg 
tablet dose (i.e., prescriptions likely to represent treatment for zoster). To avoid including prevalent 
zoster patients and misclassification of treatment of herpes simplex, we excluded persons who were 
40 years or younger at baseline, persons who had a previous diagnosis of zoster or postherpetic 
neuralgia, and persons with a previous prescription for acyclovir, valacyclovir, or famciclovir at any 
dose (26). We considered the first recorded date of the qualifying hospital contact or prescription to 
be the diagnosis date.  
In Northern Europe, chickenpox is considered a childhood disease, thus it is estimated that 
over 98% of adult Danes are seropositive to varicella-zoster virus and thereby at risk of zoster 
(27,28). Varicella vaccination is not part of the routine childhood vaccination schedule in Denmark 
and no zoster vaccine was marketed in Denmark during the study period.  
 
Covariables 
Based on a directed acyclic graph for our study (Web Figure 1), we identified potential confounders 
recorded in our data sources before or at baseline (Web Table 1). We thus included age, sex, and 
various immunosuppressive treatments and chronic conditions (2,26), including rheumatoid arthritis, 
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systemic/subacute lupus erythematosus, inflammatory bowel disease, chronic kidney disease, 
asthma, chronic obstructive pulmonary disease, use of inhaled glucocorticoids, diabetes mellitus, 
hospital-diagnosed mood disorders, and severe immunosuppression (human immunodeficiency virus 
infection, hematopoietic stem cell transplantation, other cellular immune deficiency, leukemia, 
lymphoma, myeloma, and use of oral glucocorticoids or other immunosuppressant drugs). We also 
identified highest level of education achieved [as a measure of socioeconomic status, which could 
affect lifestyle habits and health-seeking behavior (29)], and for country of origin as proxy for 
ethnicity [associated with zoster (29) and potentially linked to lifestyle through socioeconomic or 
other factors].  
 
Statistical analyses 
We characterized the study cohort at baseline, both overall and in exposure categories. For each 
exposure level, we computed the number of events, follow-up time, and incidence rate of zoster. We 
used Cox proportional hazards regression (30) stratified by 5-year birth cohorts to compute hazard 
ratios (HRs) with 95% confidence intervals (CIs) associating each exposure with zoster. We used age 
as the time scale, because of the strong association between age and zoster and because it did not 
require that we specify the nature of the association. We explored the impact of covariable 
adjustment by fitting sequential multivariable models. Model 1 adjusted for sex. Model 2 
additionally included immune-related diseases and immunosuppressive drugs. Model 3 additionally 
included country of origin and education level. Finally, Model 4 explored the effects of adding other 
relevant exposures of interest, i.e., smoking habits were adjusted additionally for weekly alcohol 
consumption, BMI, and physical activity; variables for alcohol consumption were adjusted for 
smoking status, BMI, and physical activity; and BMI and physical activity were adjusted for 
smoking status and weekly alcohol consumption. We examined associations with daily tobacco 
consumption, weekly alcohol consumption, and BMI—both as categorical variables and as 
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continuous variables in restricted cubic splines models. We used the variation inflation factor from a 
regression including variables from Model 4 to examine whether collinearity occurred. We found no 
evidence of collinearity (individual variance inflation factors ≤1.58 and mean values ≤1.12).  
We used stratified analyses to examine the possibility of effect measure modification by age 
group at baseline and sex. For example, some lifestyle factors could have an impact on immune 
function and accelerate its decline in elderly persons who already have a weaker immune system. 
Furthermore, because we expected high BMI and a sedentary lifestyle to be closely linked, and 
possibly to have a multiplicative effect, we examined associations for each BMI category in strata of 
physical activity and vice versa. In a sensitivity analysis, we examined whether adjustment for 
additional socioeconomic variables—working status and civil status—affected our main results.  
We accounted statistically for survey design and differential non-response in all analyses by 
incorporating calibrated post-survey weights computed by Statistics Denmark. These weights were 
based on selected characteristics identified through linkage to other data sources (31). We assessed 
the proportional hazards assumption for each exposure by visual inspection of log-log plots and 
found no substantial deviations.  
We performed all analyses using Stata v15. The study was approved by the Danish Data 
Protection Agency (record number 2013-41-1719). Approval by an ethics review board and informed 
consent were not required. 
 
Missing data. Some information was missing for self-reported variables. We considered data 
unlikely to be ‘missing at random’, as reporting of lifestyle variables could be related to the true 
value (e.g., missing data on alcohol consumption among heavy drinkers). Although the missingness 
mechanism cannot be identified with observational data, these data can help to frame plausible 
assumptions (32). We used three strategies to investigate missing information, i.e., we examined the 
distribution of missing data, summarized data for fully observed (or near-fully observed) variables by 
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missingness pattern, and computed odds ratios using logistic regression with an indicator for 
missingness as the dependent variable (32). We included variables from Model 4. Age was entered 
as a categorical variable. Furthermore, we compared HRs for zoster associated with study 
covariables (where available) among participants with complete data with that among survey non-
responders. For comparability, this analysis included non-responders who fulfilled study eligibility 
criteria (age>40 and no record suggesting previous zoster, postherpetic neuralgia or antiviral 
treatment) and we did not use survey information for defining covariables (e.g., rheumatoid arthritis 
was identified based on hospital-diagnoses only). 
Frequency of missing data on exposures varied between 2.1% for education to 5.1% for 
alcohol consumption (Web Table 2). Approximately 85% of subjects had complete data on all 
variables. Both descriptive analyses (Web Table 3) and multivariable logistic regression (Web Table 
4) showed that missingness was not associated with zoster, but with several confounders, including 
older age, female sex, shorter education, several chronic diseases, ‘other’ country of origin, and for 
individual exposures, with lower alcohol consumption, lower BMI, and a more sedentary lifestyle. 
This pattern is consistent with missingness that is conditionally independent of an outcome. The 
pattern also fits the study’s prospective design (32), in which the outcome was unknown at the time 
of the Survey and willingness to respond to a question was thus unlikely to be associated with later 
risk of zoster. As a complete-case regression analysis provides asymptotically unbiased estimates of 
the exposure association in situations characterized by this type of missingness (32), we used this 
approach for our analyses. We expected only minor loss of precision given the modest prevalence of 
missing data. The HRs for the association between covariables and zoster were comparable for the 




The study flowchart is presented in Figure 1. In total, 101,894 persons fulfilled the study’s eligibility 
criteria. Mean age was 58 years (standard error: 0.044) and 49.2% of participants were women 
(Table 2). The majority were Danish (92.9%) and had an intermediate level of education (49.6%). 
Baseline characteristics by levels of exposures are presented in Web Tables 5–8, showing that 
exposure categories representing the healthiest lifestyle choices (e.g., never smokers and normal-
weight persons) tended to have higher proportions of women (except for the most physically active), 
certain chronic diseases, short education, and healthy lifestyle in general. 
In total, 2,231 persons were diagnosed with zoster during 357,768 person-years of follow-up 
(mean=4.0 years; standard error=0.0023), yielding an incidence rate of 6.2 per 1,000 person-years. 
Compared with never smokers, former smokers had increased hazards for zoster (fully-adjusted HR 
1.17; 95% CI: 1.06, 1.2´30), but not current smokers (HR 1.00, 95% CI: 0.89, 1.13). Among current 
daily smokers who reported quantity of tobacco consumption (n=21,310; 98.5%), we found no dose-
response relation with risk of zoster (referent=never smokers), although sample size was low for the 
upper strata where a decreased HR cannot be excluded. Compared with low-risk alcohol 
consumption, neither intermediate-risk (HR 0.95; 95% CI: 0.84, 1.07) nor high-risk consumption 
(HR 0.99; 95% CI: 0.85, 1.15) was associated with an increased hazard of zoster. Similarly, relative 
risk was not increased in respondents who reported weekly binge drinking vs. those who did not (HR 
0.93; 95% CI: 0.77, 1.11). We also found no variation in hazard of zoster by levels of BMI 
(referent=normal weight) or physical activity (referent=light lifestyle), with HRs ranging between 
0.98 and 1.08. Analyses in which daily tobacco consumption, weekly alcohol consumption, and body 
mass index were entered as cubic splines supported the results for categorical exposure definitions 
(Figure 2).  
We did not find evidence of effect modification by age, sex, physical activity (for BMI), and 
BMI (for physical activity), but analyses were limited by few events and thus overlapping CIs (Web 
Tables 9–11).  
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Additional adjustment for working status and civil status factors had no effect on estimates 
from the main analysis (Web Table 12). HRs for zoster associated with covariables in the fully-
adjusted models are provided in Web Table 12. In a post hoc analysis, we additionally adjusted 
results for new diagnoses (recorded within the year before baseline) of diseases included in the 
Charlson Comorbidity Index (33), as we suspected residual confounding by comorbidity of the 
results for former smokers; however, this had no substantial impact on results (Web Table 13). 
 
DISCUSSION 
Our population-based cohort study found no associations between smoking, alcohol consumption, 
BMI, or level of physical activity and risk of zoster, except for a slightly increased hazard among 
former smokers compared with never smokers. 
Previous studies on smoking status and risk of zoster have had conflicting results. One case-
control (7), two cohort studies using prospectively-collected population-based data (8,9) and two 
small case-control studies using self-reported data (10,11) found a 7%–48% decreased relative risk 
of zoster among current smokers and either decreased [0.87 (9)] or slightly increased estimates of 
relative risk [1.06 to 1.27 (7,8,10,11)] among former smokers. Similarly, a U.S. population-based 
cohort study with 4,162 participants reported an HR of 0.47 (95% CI: 0.25, 0.89) for current vs. 
‘other’ smoking (12). Studies with less clear definitions of smoking (ever or unspecified) generally 
found no association with zoster (13-18). To our knowledge, only one study has tried to evaluate 
dose-response: a Japanese cohort study with 12,351 participants showed that the HRs of HZ were 
0.48 (95% CI: 0.27, 0.85) for participants who smoked 1–19 cigarettes daily and 0.56 (95% CI: 0.31, 
1.00) for those who smoked >20 cigarettes daily, compared with never smokers (9). The increased 
risk of zoster among former smokers in our study partly agrees with previous studies. It is possible 
that diagnosis of a chronic disease may both motivate smoking cessation and increase risk of zoster, 
but our post hoc analysis did not support strong confounding by recent diagnoses of chronic diseases 
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included in the Charlson Comorbiditty Index. Nevertheless, the lack of an association with current 
smoking and of a dose-response relation suggests that this finding could be explained by non-causal 
mechanisms. 
Among three small case-control studies (14,16,17), one reported an increased crude odds ratio 
(3.8; 95% CI: 1.15, 2.5) for the association between alcohol consumption (without further 
specification) and zoster. The validity of these studies was compromised by inaccurate exposure 
definitions, selection bias (e.g., due to missing data), recall bias, confounding (two presented only 
crude data), and small sample sizes (between 44 and 250 cases). In a larger case-control study 
(144,959 cases; 549,336 controls) based on routinely-collected data in the UK, Forbes et al. (7) 
found ORs for zoster close to unity among current drinkers (1.05; 99% CI: 1.02, 1.08) and former 
drinkers (1.11; 99% CI: 1.07, 1.15). A cohort study by Liu et al. (8) comprising participants in an 
Australian survey (‘The 45 and Up Study’) was comparable to our study. That study also found no 
association between zoster and consumption of <7 alcohol units per week (HR 1.02; 95% CI: 0.96, 
1.08) or ≥7 alcohol units per week (HR 1.04; 95% CI: 0.98, 1.10) compared with no consumption. 
By providing more detailed data on level of alcohol consumption, including binge drinking, our 
study provides reassuring consistency with the largely neutral findings of these well-controlled 
studies. 
Our results also confirmed the null association between BMI and zoster reported in five 
previous studies (7,8,14,17,19). Three were small case-control studies with 44 to 250 cases that 
merely compared mean BMI values in persons with and without zoster (14,17,19). The other two 
large population-based studies—conducted by Forbes et al. (7) and Liu et al. (8)—compared BMI 
categories and reported relative risk estimates for zoster of 1.00 to 1.04 for overweight and obese 
persons compared with normal-weight or lower-weight persons.  
A U-shaped association has been suggested for exercise, immune function, and risk of 
respiratory infections, with the lowest risk observed among persons with moderate exercise 
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conditioning (6). We did not find such an association between physical activity and zoster. Only Liu 
et al. (8) examined this association, albeit with less detailed data. They similarly found no increase in 
the hazard of zoster for participants reporting vigorous physical activity >1 time/week compared 
with <1 time/week (0.98; 95% CI: 0.93, 1.03) (8). 
A major strength of our study is its use of prospectively-collected data from a tax-funded 
healthcare system with no co-payment required by patients seeking help. Our study is also larger and 
has more detailed data on lifestyle factors, BMI, and important zoster risk factors, compared with 
most previous studies. Several potential weaknesses also must be considered. The response rate was 
63% in our sample. However, we believe that selection bias was limited. First, loss to follow-up was 
minimal. Second, comparisons were made internally among participants. Third, we used survey 
weights to account for differential non-response. Fourth, associations between other study variables 
and zoster were largely independent of survey participation (Web Figure 2). Finally, selection bias 
due to missing data also seems unlikely, judging from patterns of missingness (Web Table 4) (32).  
Self-reporting may have caused misclassification of exposures, but the study’s prospective 
design protected against differential recall bias. Nevertheless, in studies using survey data, there is a 
tendency for underreporting of characteristics such as BMI among overweight individuals (34) and 
smoking and alcohol consumption among frequent users (35). For exposure variables with more than 
two levels, such misreporting may result in bias towards the null for the lower and upper categories 
and away from the null for intermediate categories (36). However, our results did not indicate such 
patterns. Questionnaire data also present the risk of simultaneous misclassification of variables (e.g., 
misreports of both smoking and alcohol consumption) (36). Bias and residual confounding that stem 
from such ‘dependent non-differential misclassification’ is difficult to predict, but estimates 
remained consistent across our multivariable models. Finally, misclassification due to changes in 
lifestyle habits and BMI over time is possible, as we only had baseline data. For the same reason, 
some covariables may have acted both as confounders and mediators.  
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We supplemented hospital diagnoses of zoster with prescriptions for antivirals [positive 
predictive value=87% (26)] to increase completeness. Although this approach is likely to identify 
most zoster patients, it misses persons who never seek care or are not prescribed specific antivirals. 
Such misclassification may be differential if certain lifestyle habits are associated with health-
seeking behavior and thus with an increased chance of being diagnosed and treated for zoster 
(ascertainment bias). However, associations of interest were neutral in our study and unaffected by 
adjustment for several variables potentially associated with healthcare contacts. 
We adjusted for a wide range of zoster risk factors at baseline using data from multiple sources 
to increase completeness. Nevertheless, residual confounding remains possible due to incomplete or 
crudely defined covariables or changes in status during follow-up. This may explain the increased 
risk found in former smokers.  
Survey participation was associated with certain characteristics, such as sex and country of 
origin. However, the generalizability of our findings would be affected only if these factors modified 
study associations and if their prevalence differed in the target population (36,37). We expect that 
our results could be generalized to populations similar to the Danish population. Unfortunately, we 
were unable to conduct informative stratified analyses examining the validity of extrapolation to 
other populations, for instance those in which other ethnicities are predominant. Future studies could 
also examine other aspects of lifestyle, e.g. micronutrient intake and sleep habits, which could act as 
individual zoster risk factors or modify associations examined in the current study. 
In conclusion, we found no evidence of an association between lifestyle and anthropometric 
factors (smoking, alcohol consumption, BMI and physical activity) and risk of zoster. The increased 
risk observed among former smokers may relate to poorer general health. The continued lack of 
known modifiable risk factors for zoster underscores the need for alternative preventive measures, 
such as vaccination.  
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Data availability statement: No additional unpublished data are available as this study used 
existing data from the Danish nationwide registries which are accessible to researchers who fulfil 
local requirements following approval by the Danish Data Protection Agency, the Danish Health 
Data Authority, the National Institute of Public Health at University of Southern Denmark (data 
administrator for the Danish National Health Survey), and Statistics Denmark.
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Table 1. Definitions and a priori Working Hypotheses for Exposures of Interest in the Study on 
Lifestyle and Anthropometric Factors and Risk of Herpes Zoster, 2010 Danish National Health 
Survey. 
Variable Definition A priori working hypothesisa 
Smoking 
status  
We categorized persons as never smokers 
(referent), former smokers, or current smokers 
(daily or non-daily). 
Cigarette smoke affects both 
innate and adaptive immunity 
(3). Although cigarette smoking 
results in leukocytosis in 
humans, the function of 
circulating cells is reduced. This 
effect is thought to be mediated 
by nicotine and/or tar. We 
hypothesized that current 
smokers are at increased risk of 
zoster, while former smokers 






Among current daily smokers of tobacco, we 
calculated total daily consumption in grams 
using the following rule: 1 cigarette equals 1 
gram, 1 cigar equals 4.5 grams, 1 cheroot equals 
3 grams, and 1 pipe stop equals 3 grams of 
tobacco. We grouped total consumption by 5-
gram increments: 1–5, 6–10, 11–15, 16–20, 21–
25, 26–30, and 30+ grams. In a restricted cubic 
splines model, we included daily consumption 
as a continuous variable, rounding to the nearest 
full integer and capped at 40+ grams per day. 
Never smokers constituted the reference group.  
The risk of zoster increases with 
increasing daily tobacco 
consumption – possibly reaching 
a plateau after a certain level of 




Based on the number of standardized alcohol 
units consumed weekly, we categorized 
drinking as low-risk (≤7 units for women/≤14 
units for men); intermediate-risk (8–14 units for 
women/15–21 units for men); or high-risk (≥15 
units for women/≥22 units for men). We 
included non-drinkers in the low-risk group 
(reference group). In a restricted cubic splines 
model, we included the number of units 
consumed weekly as a continuous variable, 
capped at 80+ units, and with consumption of 0 
units as the referent. 
Alcohol has been associated 
with increased T-cell apoptosis, 
reduced interleukin-17 
production, lymphopenia in 
blood and tissues, and reduced 
activity of antigen-presenting 
cells (4). We hypothesized that 
risk of zoster increases with an 
increasing number of units of 
alcohol consumed per week.  
Binge 
drinking 
We defined binge drinkers as those who 
reported daily, almost daily, or weekly intake of 
≥5 units of alcohol on a single occasion. Those 
reporting binge drinking monthly or less, 
We hypothesized that binge 
drinking is associated with 
increased risk of zoster, similar 
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including non-drinkers, constituted the reference 
group. 




We categorized BMIb according to the World 
Health Organization definition: underweight 
(BMI<18.5 kg/m2); normal weight (BMI 18.5–
24.9 kg/m2; referent); overweight (BMI 25–29,9 
kg/m2); or obese (BMI≥30 kg/m2). In a 
restricted cubic splines model, we included BMI 
as a continuous variable, rounding to the nearest 
full integer, capped at 60+ kg/m2, with BMI = 
22 as the referent. 
Obesity is characterized by low-
grade chronic inflammation and 
also has been linked to 
functional immune deficiency, 
as evidenced by impaired 
lymphocyte proliferation to 
antigen stimulation, reduced T-
cell diversity, enhanced aging of 
the thymus, an increased risk of 
some infections among obese 
persons, and possibly reduced 
immunogenicity of vaccinations 
(5). We hypothesized that there 
is a J/U-shaped relation between 
BMI and risk of zoster, with an 
increased risk among 
underweight persons (related to 
potential undernutrition) and 




We categorized physical activity as sedentary 
(reading, watching television, or other sedentary 
activity most of the time); light (walking, 
cycling, or other light exercise ≥4 hours weekly, 
including Sunday excursions, light gardening, 
and cycling or walking to work; referent); or 
moderate/vigorous (heavy exercise and 
competitive sports regularly and several times a 
week or recreational sports, heavy gardening, or 
a similar activity ≥4 hours weekly). 
Exercise influences natural 
immunity, T-cell and B-cell 
functions, and cytokine 
responses, through 
hemodynamic and endocrine 
changes (6). The mechanisms 
are complicated; e.g., longer 
periods of intensified training in 
athletes may decrease T-cell 
functionality, while this effect is 
not observed for persons with a 
previously sedentary lifestyle. 
We hypothesized that there is a 
J/U-shaped relationship between 
physical activity and risk of 
zoster, with lowest risk among 
those performing light and 
moderate physical activity and 
highest risk among those 
participating in vigorous 
activity. 
Abbreviation: BMI=body mass index 
aDescribes how factors may impact the immune system and thus increase the potential risk of zoster. 




Table 2. Baseline Characteristics of the Study Cohort (n=101,894), 2010 Danish National Health 
Survey.a 
 Variable No. % 
Age group (years)   
40–49 27,382 30.8 
50–59 23,703 26.7 
60–69 22,351 25.1 
70–79 10,886 12.2 
80+ 4,584 5.2 
Sex   
Men 45,189 50.8 
Women 43,717 49.2 
Immunosuppressive and chronic diseases   
Rheumatoid arthritis 6,720 7.6 
Systemic lupus erythematosus 90 0.1 
Inflammatory bowel disease 1,062 1.2 
Chronic kidney disease 530 0.6 
Asthma 2,558 2.9 
Chronic obstructive pulmonary disease 6,014 6.8 
Inhaled corticosteroids 3,569 4.0 
Diabetes 6,123 6.9 
Mood disorder 4,731 5.3 
Severe immunosuppression 2,491 2.8 
Human immunodeficiency virus 56 0.1 
Other immunosuppressive disease 31 0 
Leukemia 137 0.2 
Lymphoma 316 0.4 
Myeloma 35 0 
Oral corticosteroids 1,161 1.3 
Hematopoietic stem cell transplant 62 0.1 
Other immunosuppressants 985 1.1 
Highest achieved educationb    
Short 23,747 26.7 
Intermediate  44,135 49.6 
High  21,023 23.6 
Country of originc   
Danish 82,625 92.9 
Other Western 3,226 3.6 
Non-Western 3,054 3.4 
Smoking status   
Never 35,774 40.2 
Former 30,809 34.7 
Current 22,322 25.1 
Alcohol consumptiond   
Low-risk 67,645 76.1 
Intermediate-risk  12,099 13.6 
High-risk 9,161 10.3 
Binge drinking weekly or more   
No 80,634 90.7 
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Yes 8,272 9.3 
Body mass index category   
Underweight 1,386 1.6 
Normal 39,593 44.5 
Overweight 34,050 38.3 
Obese 13,877 15.6 
Physical activity   
Sedentary 13,710 15.4 
Light 55,124 62.0 
Moderate 18,494 20.8 
Vigorous 1,577 1.8 
aIn all analyses, we included calibrated weights to statistically account for survey design and 
differential non-response. Thus, the numbers may not add up to the totals. 
bCategorized as short (<10 years), intermediate (10–15 years), and high education (>15 years), 
according to the United Nations Educational, Scientific and Cultural Organization’s (UNESCO’s) 
classification 
cDefined using an algorithm that combines data on citizenship, place of birth, and parents’ place of 
birth, as recorded in the Civil Registration System. 
dCategorized based on number of standardized alcohol units consumed weekly: low-risk (≤7 for 
women/≤14 for men) intermediate-risk (8–14 for women/15–21 for men); or high-risk (≥15 for 
women/≥22 for men).   
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Model 1 Model 2 Model 3 Model 4 
 
   HRb 95% CI HRb 95% CI HRb 95% CI HRb 95% CI 
Smoking status            
Never 834 145,274 5.74 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Former 892 123,196 7.24 1.20 1.09,1.33 1.17 1.06,1.29 1.17  1.06,1.29 1.17  1.06,1.30 
Current 505 89,298 5.66 1.04 0.92,1.17 1.00 0.89,1.13 1.00  0.89,1.13 1.00 0.89,1.13 
Tobacco consumption 
(grams/day)c 
           
1–5 42 6,156 6.84 1.12 0.80,1.56 1.09 0.78,1.51 1.08  0.78,1.50 1.09  0.78,1.51 
6–10 142 19,234 7.40 1.24 1.02,1.49 1.20 0.99,1.45 1.18  0.98,1.43 1.19  0.98,1.44 
11–15 96 18,776 5.09 0.93 0.74,1.17 0.89 0.71,1.11 0.87 0.69,1.09 0.88 0.70,1.11 
16–20 116 21,622 5.38 1.05 0.85,1.30 0.99 0.80,1.23 0.97  0.78,1.21 0.98  0.78,1.23 
21–25 21 5,133 4.07 0.83 0.52,1.32 0.77 0.48,1.24 0.76  0.47,1.21 0.77  0.48,1.24 
26–30 20 5,103 3.89 0.79 0.50,1.26 0.73 0.46,1.17 0.72  0.45,1.15 0.74  0.46,1.18 
30+ 15 3,411 4.45 0.93  0.50,1.70 0.84 0.46,1.56 0.83  0.45,1.53 0.84 0.46,1.54 
Alcohol consumptiond            
Low-risk 1,697 272,241 6.23 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Intermediate-risk 309 48,926 6.32 0.95 0.83,1.07 0.96 0.85,1.09 0.96  0.84,1.08 0.95 0.84,1.07 
High-risk   225 36,601 6.15 1.00 0.86,1.15 1.00 0.86,1.15 0.99 0.86,1.15 0.99  0.85,1.15 
Binge drinking weekly or 
more 
           
No 2,072 324,431 6.39 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Yes 160 33,338 4.79 0.94 0.78,1.12 0.93 0.77,1.11 0.92 0.77,1.11 0.93  0.77,1.11 
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Body mass index 
category 
           
Underweight 42 5,256 7.98 1.00 0.71, 1.41 0.95 0.67, 1.33 0.95   0.67, 1.33 0.96  0.69, 1.36 
Normal 1,015 159,066 6.38 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Overweight 825 137,547 6.00 0.99 0.90,1.10 0.99 0.90,1.10 1.00  0.91,1.10 0.99  0.90,1.09 
Obese 349 55,899 6.25 1.04 0.91,1.18 1.02  0.89,1.16 1.02  0.89,1.16 1.01  0.88,1.15 
Physical activity            
Sedentary 378 52,680 7.18 1.04 0.92, 1.18 0.99  0.87, 1.12 0.99 0.87, 1.12 0.99  0.87, 1.13 
Light 1,429 223,098 6.41 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Moderate 393 75,566 5.20 0.97 0.87,1.09 0.99 0.88,1.11 0.99 0.88,1.11 0.98  0.88,1.11 
Vigorous 31 6,424 4.88 1.07  0.72, 1.59 1.08  0.73, 1.62 1.08 0.73, 1.62 1.08  0.72, 1.61 
Abbreviation: CI, confidence interval; HR, hazard ratio  
aIn all analyses, we included calibrated weights to statistically account for survey design and differential non-response. Thus, the numbers may not add 
up to the totals. 
bComputed using Cox regression with age as underlying time scale and stratified by birth cohort. Model 1 adjusted for sex. Model 2 adjusted 
additionally for the immunosuppressive and chronic diseases listed in Table 2, and Model 3 additionally included country of origin and education level. 
Model 4 additionally adjusted for other lifestyle factors, i.e., smoking status was adjusted for weekly alcohol consumption, BMI, and physical activity; 
weekly alcohol consumption and binge drinking were adjusted for smoking status, BMI, and physical activity; and BMI and physical activity were 
adjusted for smoking status and weekly alcohol consumption. 
cAmong daily smokers compared with never smokers.  
dCategorized based on number of standardized alcohol units consumed weekly: low-risk (≤7 for women/≤14 for men) intermediate-risk (8–14 for 




Figure 1. Flowchart for the Study on Lifestyle and Anthropometric Factors and Risk of 
Herpes Zoster, Based on Data from the 2010 Danish National Health Survey. 
 
Figure 2. Hazard Ratios (95% confidence intervals) for Herpes Zoster Associated with (A) 
Daily Tobacco Consumption, (B) Weekly Alcohol Consumption and (C) Body Mass Index 
(BMI, kg/m2), Entered as Restricted Cubic Spline Models (Solid and Dashed Lines) and as 
Categorical Variables (Circles with Error Bars), 2010 Danish National Health Survey.  
